Logo

William Blair

William Blair Initiates Coverage of Bio-Techne With Outperform Rating

The investment bank emphasized Bio-Techne's position in multiple high-growth and attractive end markets, including cell and gene therapy, spatial biology, and liquid biopsy.

William Blair Initiates Coverage of MDxHealth With Outperform Rating

A letter to investors noted the company's dedicated focus on prostate cancer diagnostics, which de-risks the firm's growth outlook and path to profitability.

William Blair Downgrades Lucira Health to Market Perform

As a result of the downgrade, the bank also significantly reduced revenue and volume estimates for 2021 and 2022.

William Blair Initiates Coverage of 10x Genomics With Outperform Rating

Analysts for the investment bank, which co-managed a recent 10x stock offering, said the company could "redefine the way biological analysis is performed."

Roche to Acquire GenMark Diagnostics for $1.8B

Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share.

Sep 11, 2020

10x Genomics Prices Upsized $440M Public Offering

Sep 9, 2020

10x Genomics to Sell 3.5M Shares in Public Offering

Aug 11, 2020

JP Morgan, Cowen, William Blair Initiate Coverage of Berkeley Lights

Jul 16, 2020

Adaptive Biotechnologies to Raise $240M in Public Stock Offering

May 11, 2020

William Blair Upgrades Meridian Bioscience to Outperform

Jan 24, 2020

Adaptive Biotechnologies Prices Public Offering of Stock

Jan 21, 2020

Adaptive Biotechnologies Announces Preliminary FY19 Revenue Increase, $257M Stock Offering

Jul 26, 2018

Veracyte Prices $51.3M Public Offering

Jan 5, 2018

Illumina Remains NGS Leader But Competitors Expected to Gain, Survey Finds
Premium

Jul 18, 2017

Investment Banks Upgrade Quidel Shares on Acquisition of Alere Assets

May 21, 2015

Investment Banks Downgrade Bruker on Resignation of CFO

May 1, 2015

William Blair Upgrades PacBio Shares on Technology Improvements, Expanded Applications

Apr 21, 2015

Survey Finds High Interest in Long-Range Genome Data, Nanopore Tech While Illumina Rules NGS Market
Premium

Jan 20, 2015

Investment Banks Upgrade Fluidigm, Hologic

Jun 23, 2014

William Blair Upgrades Sequenom to Outperform

Aug 2, 2013

Piper Jaffray Upgrades PacBio Following Earnings Results

Jul 25, 2013

William Blair Downgrades Sequenom, Citing Coding Issues and Increased Competition; Shares Down Sharply

Jul 19, 2013

William Blair Begins Coverage of Waters with Market Perform Rating

Jan 22, 2013

Analysts Speculate on Potential Life Technologies Sale

Oct 25, 2012

Survey Indicates Life Tech Remains Leader of qPCR Research Market, But Faces Some Pricing Pressure
Premium

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.